Hepatocellular Carcinoma (HCC) continues to pose a substantial global health challenge
due to its high incidence and limited therapeutic options. In recent years, the Janus Kinase …

Liver cancer is the second most lethal cancer in the world with limited treatment options.
Hepatocellular carcinoma (HCC), which accounts for more than 80% of all liver cancers, has …

Liver cancer (LC) poses a significant global health challenge due to its high incidence and
poor prognosis. Current systemic treatment options, such as surgery, chemotherapy …

Hepatocellular carcinoma (HCC) is the fifth most common type of cancers worldwide.
However, current therapeutic approaches for this epidemic disease are limited, and its 5 …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. It
can be caused by chronic liver cell injury with resulting sustained inflammation, eg, triggered …

Background & Aims: Although the natural history and pathologic characteristics of human
hepatocellular carcinoma (HCC) are well documented, the molecular pathogenesis of HCC …

The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway,
essential for cellular communication, orchestrates a myriad of physiological and pathological …

Hepatocellular carcinoma is an end-stage complication of non-alcoholic fatty liver disease
(NAFLD). Inflammation plays a critical role in the progression of non-alcoholic fatty liver …

Hepatocellular carcinoma (HCC) is one the most common malignancies and has poor
prognosis in patients. The aim of the present study is to explore the clinical significance of …

Hepatocellular carcinoma is a substantial health concern. It is currently the third dominating
cause of mortality associated with cancer worldwide. The development of hepatocellular …